Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
The Annals of Thoracic Surgery|January 1, 2020
Heterotaxy Is Not a Risk Factor for Adverse Long-Term Outcomes After Fontan CompletionSupreet P Marathe, Diana Zannino, Jacob Y Cao, et al.International Journal of Cardiology|January 20, 2017
Three decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedureChin Leng Poh, Diana Zannino, Robert G Weintraub, et al.The Annals of Thoracic Surgery|October 10, 2018
Two Ventricles Are Not Better Than One in the Fontan Circulation: Equivalent Late OutcomesSupreet P Marathe, Diana Zannino, William Y Shi, et al.Seminars in Thoracic and Cardiovascular Surgery|December 3, 2017
Twenty-Five Year Outcomes of the Lateral Tunnel Fontan ProcedureThomas G Wilson, William Y Shi, Ajay J Iyengar, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 28, 2016
No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patientsAjay J Iyengar, David S Winlaw, John C Galati, et al.Congenital Heart Disease|January 22, 2019
Creatinine-based estimation of glomerular filtration rate in patients with a Fontan circulationThomas G Wilson, Yves d'Udekem, David S Winlaw, et al.International Journal of Cardiology|June 4, 2016
The Fontan epidemic: Population projections from the Australia and New Zealand Fontan RegistryChris Schilling, Kim Dalziel, Russell Nunn, et al.Circulation|September 10, 2014
Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New ZealandYves d'Udekem, Ajay J Iyengar, John C Galati, et al.International Journal of Cardiology|March 4, 2016
Use of ACE inhibitors in Fontan: Rational or irrational?Thomas G Wilson, Ajay J Iyengar, David S Winlaw, et al.Heart Asia|July 13, 2019
Inter-rater and intra-rater reliability and agreement of echocardiographic diagnosis of rheumatic heart disease using the World Heart Federation evidence-based criteriaBo Remenyi, Jonathan Carapetis, John W Stirling, et al.Pageof 6